On the basis of the documentary analysis and interview, we noted that the total funds in the four interventions whose identified axes made it possible to know how the resources mobilized for the AIDS response were distributed during the period of 2008 to 2017. These funds are distributed as follows: Treatment: 1,016,982,472 USD; Prevention: 302,542,391 USD; Governance: 459,246,584 USD; Mitigation of the impact: 115,757,443 USD. It should be noted that the analysis of resource allocations by component during the period 2008 to 2017 reveals significant disparities. Indeed, it was noted that the treatment component has received significant funding compared to the other components. It is followed by governance, prevention and impact mitigation which happens to be the component that received less funding compared to the other four (4) components.
References
[1]
Joint United Nations Programme on HIV/AIDS (UNAIDS) (2010) UNAIDS Report on the Global AIDS Epidemic 2010. Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva.
[2]
Lazarus, J.V., Curth, N., Bridge, J. and Atun, R. (2010) Know Your Epidemic, Know Your Response: Targeting HIV in DRC. AIDS, 24, S95-S99. https://doi.org/10.1097/01.aids.0000390095.98800.42
[3]
Kates, J., Boortz, K., Lief, E., Avila, C. and Gobet, B. (2010) Financing the Response to AIDS in Low- and Middle-Income Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009. Kaiser Family Foundation, San Francisco.
[4]
Joint United Nations Programme on HIV/AIDS (UNAIDS), National AIDS Spending Assessment (2008) A Notebook on Methods, Definitions and Procedures to Measure HIV and AIDS Financial Flows and Expenditure at the Country Level. Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva.
[5]
Joint United Nations Programme on HIV/AIDS (UNAIDS) (2008) National AIDS Spending Assessment (NASA) (2008) Classification and Definitions. Joint United Nations Programme on HIV/AIDS, Geneva.
[6]
World Health Organization, World Bank, United States Agency for International Development (2003) Guide to Producing National Health Accounts: with Special Applications for Low-Income and Middle-Income Countries. World Health Organizations, Geneva.
[7]
The Global Fund to Fight AIDS, Tuberculosis and Malaria: Grant Portfolio Database (2021). http://portfolio.theglobalfund.org/en/Home/Index
[8]
Rice, D.P. (2000) Cost of Illness Studies: What Is Good about Them? Injury Prevention, 6, 177-179.
[9]
Drummond, M. (1992) Cost-of-Illness Studies: A Major Headache? PharmacoEconomics, 2, 1-4. https://doi.org/10.2165/00019053-199202010-00001
[10]
Joint United Nations Programme on HIV/AIDS (UNAIDS) (2008) Report on the Global AIDS Epidemics. Joint United Nations Programme on HIV/AIDS, Geneva.
[11]
UNAIDS (2009) National AIDS Spending Assessment Country Reports. http://www.unaids.org/en/KnowledgeCentre/HIVData/Tracking/Nasa.asp
[12]
The Global Fund to Fight AIDS, Tuberculosis and Malaria (2008) Five-Year Evaluation Study Area 3: Health Impact of Scaling Up Against HIV, TB & Malaria. The Global Fund, Geneva.
[13]
The Global Fund to Fight AIDS, Tuberculosis and Malaria (2006) Review of the Global Fund Grant Portfolio. Funding the Right Things? Technical Evaluation Group Technical Report. The Global Fund, Geneva.
[14]
World Bank (2010) World Development Indicators Database. World Bank, Washington DC.
[15]
The Global Fund to Fight AIDS, Tuberculosis and Malaria (2002) The Framework Document of the Global Fund to Fight AIDS, Tuberculosis and Malaria. The Global Fund, Geneva.
[16]
Vernazza, P., Hirschel, B., Bernasconi, E. and Flepp, M. (2008) Les personnes seropositives ne souffrant d’aucune autre MST et suivant un traitment antiretroviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletin des Médecins Suisses, 89, 165-169. https://doi.org/10.4414/bms.2008.13252
[17]
Wilson, D., Law, M., Grulich, E., Cooper, D. and Kaldor, J. (2008) Relation between HIV Viral Load and Infectiousness: A Model-Based Analysis. Lancet, 372, 314-320. https://doi.org/10.1016/S0140-6736(08)61115-0
[18]
Achrekar, A. (n.d.) The U.S. President’s Emergency Plan for AIDS Relief: PEPFAR Country Statistics. http://www.pepfar.gov/countries
[19]
Izazola-Licea, J.A., Wiegelmann, J., Aran, C., Guthrie, T., De Lay, P., Avila Figueroa and C. (2009) Financing the Responce to HIV in Low-Income and Middle-Income Countries. Journal of Acquired Immune Deficiency Syndromes, 52, 119-126. https://doi.org/10.1097/QAI.0b013e3181baeeda
[20]
Halperin, D.T., Steiner, M.J., Cassell, M.M., Green, E.C., Hearst, N., Kirby, D., Gayle, H.D. and Cates, W. (2004) The Time Has Come for Common Ground on Preventing Sexual Transmission of HIV. Lancet, 364, 1913-1915. https://doi.org/10.1016/S0140-6736(04)17487-4
[21]
Mathers, B., Degenhardt, L., Ali, H., Wiessing, L., Hickman, M., Mattick, R., Myers, B., Ambekar, A. and Strathdee, S. (2010) HIV Prevention, Treatment, and Care Services for People Who Inject Drugs: A Systematic Review of Global, Regional, and National Coverage. Lancet, 375, 1014-1028. https://doi.org/10.1016/S0140-6736(10)60232-2
[22]
Strathdee, S.A., Hallett, T.B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R. and Hankins, C. (2010) HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet, 376, 398-400. https://doi.org/10.1016/S0140-6736(10)60743-X
